JAMA Oncology Author Interviews

JAMA Oncology Author Interviews

JAMA Network

Episodes 129
Avg. Duration 14m
Activity Declining
Since Feb 2015
Latest Episode Nov 2025

Outreach Signals

Features Guests

Publishing Details

Schedule
Monthly
Format
Episodic
Consistency
77%
Hosting
rss.libsyn.com

Contact & Outreach

About This Podcast

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Explore Statistics

Recent Episodes

Metastatic Recurrence Among Adolescents and Young Adults With Cancer

Nov 26, 2025 11m

Interview with Ann Brunson, MS, and Theresa H. M. Keegan, PhD, MS, authors of Metastatic Recurrence Among Adolescents and Young Adults With Cancer. Hosted by Vivek Subbiah, MD. Related Content: …

Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality

Oct 30, 2025 12m

Interview with Yiwen Zhang, PhD, and Edward L. Giovannucci, MD, ScD, authors of Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality. Hosted by Vivek…

Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer

Sep 18, 2025 13m

Interview with Jiyoung Ahn, PhD, author of Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer. Hosted by Vivek Subbiah, MD. Related Content: Oral Bacterial and Fungal…

Proportional Sedation for Persistent Agitated Delirium in Palliative Care

Jul 31, 2025 17m

Interview with David Hui, MD, and Eduardo Bruera, MD, authors of Proportional Sedation for Persistent Agitated Delirium in Palliative Care: A Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.…

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance

May 29, 2025 18m

Interview with Thorir Einarsson Long, MD, PhD, and Ola Landgren, MD, PhD, authors of New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance. Hosted by Vivek Subbiah, MD.…

Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury

Apr 24, 2025 12m

Interview with Shruti Gupta, MD, MPH, author of Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury. Hosted by Vivek Subbiah, MD. Related Content: Intravenous Magnesium and…

Accelerated Aging in Survivors of Childhood Cancer

Mar 20, 2025 19m

Interview with Jennifer M. Yeh, PhD, and Lisa R. Diller, MD, authors of Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions. Hosted by Vivek Subbiah,…

Academic-Community Partnership and Deaths in Promyelocytic Leukemia

Feb 27, 2025 18m

Interview with Anand P. Jillella, MD, author of Academic-Community Partnership and Deaths in Promyelocytic Leukemia: The Nonrandomized ECOG-ACRIN EA9131 Trial. Hosted by Vivek Subbiah, MD. Related…

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Jan 30, 2025 11m

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.…

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020

Dec 05, 2024 16m

Interview with Katrina A. B. Goddard, PhD, author of Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. Hosted by Vivek Subbiah, MD. Related Content: …

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

Nov 21, 2024 18m

Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek…

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

Oct 24, 2024 20m

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.…

Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

Sep 05, 2024 17m

Interview with Eileen M. O'Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD. Related Content: Lynch Syndrome and Somatic…

Identification of Immune Checkpoint Inhibitor–Induced Diabetes

Aug 29, 2024 14m

Interview with Michelle Rengarajan, MD, PhD, author of Identification of Immune Checkpoint Inhibitor–Induced Diabetes. Hosted by Vivek Subbiah, MD. Related Content: Identification of Immune…

Neoadjuvant Exercise Therapy in Prostate Cancer

Jul 18, 2024 19m

Interview with Lee W. Jones, PhD, author of Neoadjuvant Exercise Therapy in Prostate Cancer: A Phase 1, Decentralized Nonrandomized Controlled Trial. Hosted by Vivek Subbiah, MD. Related Content: …

Endometrial Thickness as Diagnostic Triage for Endometrial Cancer in Black Individuals

Jun 27, 2024 15m

Interview with Kemi M. Doll, MD, MSCR, author of Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals. Hosted by Vivek Subbiah, MD. Related Content: Endometrial…

T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

Apr 18, 2024 19m

Interview with Roni Shouval, MD, PhD, author of T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy. Hosted by Vivek Subbiah, MD. Related Content: T-Cell Malignant Neoplasms…

Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time

Mar 21, 2024 25m

Interview with Tobias Janowitz, MD, PhD, and Karen Winkfield, MD, PhD, authors of Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time. Hosted by Vivek…

Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer

Feb 29, 2024 14m

Interview with José P. Leone, MD, author of Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer. Hosted by Nora L. (Mary) Disis, MD. Related Content: …

Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US

Jan 04, 2024 17m

Interview with Sajid A. Khan, MD, author of Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. Hosted by Mary L. (Nora) Disis, MD. Related Content: …

Frequently Asked Questions

How many episodes does JAMA Oncology Author Interviews have?

JAMA Oncology Author Interviews has published 129 episodes since February 2015, covering topics in Health & Fitness, Medicine.

Is JAMA Oncology Author Interviews still active?

JAMA Oncology Author Interviews is currently declining with new episodes monthly. Average episode length is 14m.

How do I contact JAMA Oncology Author Interviews for sponsorship or guest appearances?

Sign up on Grep.FM to access contact details for JAMA Oncology Author Interviews, including email and social media links.

Similar Podcasts